NLRP3 and nephrolithiasis susceptibility caused by SLC26A1: For example, Lv et al. discovered that XIST inhibition alleviates renal inflammation and oxidative damage induced by calcium oxalate nephrolithiasis through the miR- 223/NLRP3 pathway [42].